Remdesivir and mortality reduction in COVID-19 patients: a systematized subgroup analysis of clinical trials Emilio Jesús Alegre-del Rey; Manuel David Gil-Sierra; Catalina Alarcón de la Lastra-Romero; Marina Sánchez-Hidalgo;

Inclusion of omalizumab in a trastuzumab desensitization protocol Ester María Barreiro-Fernández; Manuel David Gil-Sierra; María del Pilar Briceño-Casado; Carmen Martínez-Díaz; Esmeralda Ríos-Sánchez;

Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain Estela Moreno-Martínez; Javier de la Serna-Torraba; Vicente Escudero-Vilaplana; José Ángel Hernández-Rivas; Marina Sánchez-Cuervo; Raquel Sánchez-Hernández;